Moors & Cabot, Inc. Care Dx, Inc. Transaction History
Moors & Cabot, Inc.
- $1.9 Billion
- Q1 2025
A detailed history of Moors & Cabot, Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 11,325 shares of CDNA stock, worth $200,905. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,325Holding current value
$200,905% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
230Shares Held
56.8MCall Options Held
51.2KPut Options Held
46K-
Black Rock Inc. New York, NY5.29MShares$93.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$85.8 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.67MShares$47.3 Million0.01% of portfolio
-
State Street Corp Boston, MA2.48MShares$44.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.35MShares$41.6 Million0.45% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $948M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...